Analogs of GLP-1 are used for the treatment of type 2 diabetes, and other functions of GLP-1 include reducing appetite and decreasing the quantity and frequency of food consumption, leading to an early feeling of ‘fullness’ [11]. This evidence concerns the gene GCG and type 2 diabetes mellitus.